ADIPOQ and COVID-19: Our results show that adiponectin levels increased linearly with aging, and adiponectin serum content was also higher in non-obese patients who died and in older patients who required IC, which could reflect an attempt by the adipose tissue to counteract inflammation in COVID-19 (21).